These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
522 related items for PubMed ID: 19565416
1. Profile of long-acting reversible contraception users in Europe. Haimovich S. Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416 [Abstract] [Full Text] [Related]
2. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A. Hum Reprod; 2014 Oct 10; 29(10):2163-70. PubMed ID: 25085802 [Abstract] [Full Text] [Related]
3. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W, Bahamondes MV, Bahamondes L. Hum Reprod; 2014 Jul 10; 29(7):1393-9. PubMed ID: 24812309 [Abstract] [Full Text] [Related]
4. Study of long-acting reversible contraceptive use in a UK primary care database: validation of methodology. Cea Soriano L, Wallander MA, Andersson SW, Requena G, García-Rodríguez LA. Eur J Contracept Reprod Health Care; 2014 Feb 10; 19(1):22-8. PubMed ID: 24229345 [Abstract] [Full Text] [Related]
5. Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives. Ferreira JM, Nunes FR, Modesto W, Gonçalves MP, Bahamondes L. Contraception; 2014 Jan 10; 89(1):17-21. PubMed ID: 24156884 [Abstract] [Full Text] [Related]
6. [The end of IUD marketing in the United States: what does it mean for American women?]. Forrest JD. Contracept Fertil Sex (Paris); 1987 Mar 10; 15(3):291-300. PubMed ID: 12341479 [Abstract] [Full Text] [Related]
7. Long-acting reversible contraceptive (LARCs) methods. Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV. Best Pract Res Clin Obstet Gynaecol; 2020 Jul 10; 66():28-40. PubMed ID: 32014434 [Abstract] [Full Text] [Related]
8. Prevalence and factors predictive of long-acting reversible contraceptive use in a tertiary hospital in urban Ghana. Dassah ET, Odoi AT, Owusu-Asubonteng G. Eur J Contracept Reprod Health Care; 2013 Aug 10; 18(4):293-9. PubMed ID: 23650905 [Abstract] [Full Text] [Related]
9. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya. Hubacher D, Masaba R, Manduku CK, Chen M, Veena V. Contraception; 2015 Apr 10; 91(4):295-300. PubMed ID: 25601351 [Abstract] [Full Text] [Related]
10. Attitudes toward long-acting reversible contraception among young women seeking abortion. Rose SB, Cooper AJ, Baker NK, Lawton B. J Womens Health (Larchmt); 2011 Nov 10; 20(11):1729-35. PubMed ID: 21923281 [Abstract] [Full Text] [Related]
11. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun 10; 18(101):125-30. PubMed ID: 19637436 [Abstract] [Full Text] [Related]
12. Long-acting reversible contraception: a review in special populations. Prescott GM, Matthews CM. Pharmacotherapy; 2014 Jan 10; 34(1):46-59. PubMed ID: 24130075 [Abstract] [Full Text] [Related]
13. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system. Weisberg E, Bateson D, McGeechan K, Mohapatra L. Eur J Contracept Reprod Health Care; 2014 Feb 10; 19(1):5-14. PubMed ID: 24229367 [Abstract] [Full Text] [Related]
14. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users. Wong RC, Bell RJ, Thunuguntla K, McNamee K, Vollenhoven B. Contraception; 2009 Nov 10; 80(5):452-6. PubMed ID: 19835719 [Abstract] [Full Text] [Related]
15. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database. Agostini A, Godard C, Laurendeau C, Benmahmoud Zoubir A, Lafuma A, Lévy-Bachelot L, Gourmelen J, Linet T. Eur J Contracept Reprod Health Care; 2018 Dec 10; 23(6):421-426. PubMed ID: 30499732 [Abstract] [Full Text] [Related]
16. Changes in body composition in women using long-acting reversible contraception. Silva Dos Santos PN, Madden T, Omvig K, Peipert JF. Contraception; 2017 Apr 10; 95(4):382-389. PubMed ID: 28041992 [Abstract] [Full Text] [Related]
17. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners. Nanda G, Rademacher K, Solomon M, Mercer S, Wawire J, Ngahu R. Eur J Contracept Reprod Health Care; 2018 Aug 10; 23(4):303-308. PubMed ID: 30198796 [Abstract] [Full Text] [Related]
18. [Use of contraceptives in Norway in 2005]. Skjeldestad FE. Tidsskr Nor Laegeforen; 2007 Nov 01; 127(21):2803-5. PubMed ID: 17987070 [Abstract] [Full Text] [Related]
19. Women's awareness of long-acting, reversible contraceptive methods (LARCs) in community family planning clinics and general practice. Mansour D, Rosales C, Cox M. Eur J Contracept Reprod Health Care; 2008 Dec 01; 13(4):396-9. PubMed ID: 19117255 [Abstract] [Full Text] [Related]
20. Improved access increases postpartum uptake of contraceptive implants among HIV-positive women in Rwanda. Dhont N, Ndayisaba GF, Peltier CA, Nzabonimpa A, Temmerman M, van de Wijgert J. Eur J Contracept Reprod Health Care; 2009 Dec 01; 14(6):420-5. PubMed ID: 19929645 [Abstract] [Full Text] [Related] Page: [Next] [New Search]